The Development of Ovarian Tumours in Ovaries Grafted from Mice Pretreated with Dimethylbenzanthracene Inhibition by the Presence of Normal Ovarian Tissue
1960

Inhibition of Ovarian Tumours by Normal Tissue

Sample size: 64 publication Evidence: moderate

Author Information

Author(s): June Marchant

Primary Institution: Cancer Research Laboratories, Medical School, Birmingham

Hypothesis

Does the presence of normal ovarian tissue inhibit the development of tumours in ovaries from mice treated with a carcinogen?

Conclusion

The presence of normal ovarian tissue significantly inhibits the development of ovarian tumours in mice treated with DMBA.

Supporting Evidence

  • 14 out of 18 untreated mice with bilateral grafts of pretreated ovaries developed ovarian tumours.
  • In 16 untreated mice with unilateral grafts, only 4 microscopic tumours were found in the grafts of pretreated ovaries.
  • Only 1 microscopic ovarian tumour was found in 13 DMBA-treated mice with unilateral grafts.
  • 17 DMBA-treated mice with bilateral normal ovaries did not develop any ovarian tumours.

Takeaway

When normal ovaries were put into mice that had been treated with a cancer-causing substance, fewer tumours developed, showing that normal tissue can help prevent cancer.

Methodology

Young adult virgin female mice were treated with DMBA and underwent ovarian grafting with normal and treated ovaries, followed by observation for tumour development.

Limitations

The study was limited to a specific strain of mice and the long-term effects of the grafts were not fully explored.

Participant Demographics

Female mice of the IF strain and its F1 hybrids.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication